Skip to Content
Merck
CN

06-203

Anti-SHC Antibody

Upstate®, from rabbit

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

rabbit

antibody product type

primary antibodies

clone

polyclonal

species reactivity

pig, rat, human, mouse

manufacturer/tradename

Upstate®

technique(s)

immunohistochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable

isotype

IgG

NCBI accession no.

UniProt accession no.

shipped in

dry ice

Quality Level

Gene Information

human ... SHC1(6464)

General description

46, 52, 66 kDa

Immunogen

Recombinant GST fusion protein corresponding to amino acids 366-473 of human SHC-SH2

Application

Anti-SHC Antibody is an antibody against SHC for use in IH, IP & WB.
Research Category
Signaling
Research Sub Category
Cytoskeletal Signaling

Biochem/physiol Actions

Recognizes SHC proteins.

Physical form

Format: Purified
Immunoaffinity Purified immunoglobulin in 0.2 Tris-glycine, pH 7.4, 0.15M NaCl, 0.05% sodium azide before the addition of glycerol to 30%
Protein A purified

Preparation Note

Maintain for 2 years at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
Positive Control Included: Non-Stim A431 Cell Lysate (12-301)
routinely evaluated by immunoblot on RIPA lysates from human A431 carcinoma cells or mouse 3T3 RIPA cell lysate

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10-13 - German Storage Class 10 to 13

Regulatory Information

新产品
This item has

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Z Tu et al.
Blood, 98(7), 2028-2038 (2001-09-25)
SH2-containing inositol 5'-phosphatase (SHIP) modulates the activation of immune cells after recruitment to the membrane by Shc and the cytoplasmic tails of receptors. A novel SHIP isoform of approximately 104 kd expressed in primitive stem cell populations (s-SHIP) is described.
Iron modulates cell survival in a Ras- and MAPK-dependent manner in ovarian cells.
Bauckman, KA; Haller, E; Flores, I; Nanjundan, M
Cell Death & Disease null
Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin alpha4beta1 and cell adhesion in hematopoietic cells.
Eiichiro Kanda, Zhen-Hua Jin, Daisuke Mizuchi, Ayako Arai, Osamu Miura
Biochemical and biophysical research communications null
Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor.
Cicenas, J; Kung, W; Eppenberger, U; Eppenberger-Castori, S
Cancers null
Vivek Subbiah et al.
Cancer discovery, 8(7), 836-849 (2018-04-17)
The receptor tyrosine kinase rearranged during transfection (RET) is an oncogenic driver activated in multiple cancers, including non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC), and papillary thyroid cancer. No approved therapies have been designed to target RET; treatment

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service